Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept dose-response study of inhaled fluticasone propionate in COPD
2005-001043-32Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by University of Dundee. Primary endpoints: Serum C-reactive protein (CRP) and High-sensitivity C-reactive protein (hs-CRP). Started Apr 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-001043-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001043-32.